| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 3.60e-07 | 3 | 143 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 8.31e-07 | 25 | 143 | 5 | GO:0031683 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.19e-06 | 12 | 143 | 4 | GO:0017154 | |
| GeneOntologyMolecularFunction | alkylglycerophosphoethanolamine phosphodiesterase activity | 3.56e-06 | 5 | 143 | 3 | GO:0047391 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.14e-06 | 18 | 143 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.52e-05 | 28 | 143 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.24e-04 | 14 | 143 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 DNAH10 ATG7 MYO6 ABCA12 DYNC2H1 MYO18A ATP10B ABCC6 DNAH14 ATAD1 ABCA6 HFM1 ABCC2 | 1.35e-04 | 614 | 143 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.39e-04 | 37 | 143 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DNAH3 DNAH10 ABCA12 DYNC2H1 MYO18A ATP10B ABCC6 GNA14 ATAD1 ABCA6 HFM1 GNA11 GNAQ GNAS ABCC2 GNAZ | 1.40e-04 | 775 | 143 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.07e-04 | 118 | 143 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.71e-04 | 18 | 143 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | RHCG MYO6 DCTN2 KTN1 NCKIPSD MYO18A ARFGEF1 NUF2 SPAG5 TTLL7 KIFAP3 DST LRRC27 SCN5A KCNMA1 CCR5 GNAS IQGAP3 MYBPC2 | 3.23e-04 | 1099 | 143 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 DNAH10 ABCA12 DYNC2H1 MYO18A ATP10B ABCC6 ATAD1 ABCA6 HFM1 ABCC2 | 3.41e-04 | 441 | 143 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DNAH3 DNAH10 ABCA12 DYNC2H1 MYO18A ATP10B ABCC6 GNA14 ATAD1 ABCA6 HFM1 GNA11 GNAQ GNAS ABCC2 GNAZ | 3.42e-04 | 839 | 143 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DNAH3 DNAH10 ABCA12 DYNC2H1 MYO18A ATP10B ABCC6 GNA14 ATAD1 ABCA6 HFM1 GNA11 GNAQ GNAS ABCC2 GNAZ | 3.47e-04 | 840 | 143 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DNAH3 DNAH10 ABCA12 DYNC2H1 MYO18A ATP10B ABCC6 GNA14 ATAD1 ABCA6 HFM1 GNA11 GNAQ GNAS ABCC2 GNAZ | 3.47e-04 | 840 | 143 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.16e-04 | 49 | 143 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 6.48e-04 | 55 | 143 | 4 | GO:0042974 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.39e-03 | 8 | 143 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.40e-03 | 31 | 143 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.60e-03 | 70 | 143 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.68e-03 | 33 | 143 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.77e-03 | 9 | 143 | 2 | GO:0010854 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.21e-03 | 10 | 143 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 2.68e-03 | 11 | 143 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 2.86e-03 | 82 | 143 | 4 | GO:1990756 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating dopamine receptor signaling pathway | 2.50e-05 | 9 | 140 | 3 | GO:0060158 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SEMG1 SEMG2 DNAH3 SPAG1 DNAH10 DYNC2H1 DCTN2 KTN1 CNTRL RTTN HAUS3 NUF2 ARMCX3 DNAH14 SPAG5 TTLL7 KIFAP3 GDA DST CFAP69 | 3.14e-05 | 1058 | 140 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | olfactory nerve formation | 4.57e-05 | 2 | 140 | 2 | GO:0021628 | |
| GeneOntologyBiologicalProcess | forebrain neuron development | 4.86e-05 | 30 | 140 | 4 | GO:0021884 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 5.86e-05 | 99 | 140 | 6 | GO:0021954 | |
| GeneOntologyBiologicalProcess | ion channel modulating, G protein-coupled receptor signaling pathway | 6.44e-05 | 12 | 140 | 3 | GO:0099105 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway | 8.33e-05 | 13 | 140 | 3 | GO:0007207 | |
| GeneOntologyBiologicalProcess | germ cell development | SEMG1 SEMG2 CNTRL PRAMEF1 PRAMEF2 PRAMEF13 PIK3CA PRAMEF14 HFM1 GNAS CFAP69 VPS13B | 1.13e-04 | 482 | 140 | 12 | GO:0007281 |
| GeneOntologyBiologicalProcess | positive regulation of serine-type peptidase activity | 1.37e-04 | 3 | 140 | 2 | GO:1902573 | |
| GeneOntologyBiologicalProcess | olfactory nerve morphogenesis | 1.37e-04 | 3 | 140 | 2 | GO:0021627 | |
| GeneOntologyBiologicalProcess | positive regulation of serine-type endopeptidase activity | 1.37e-04 | 3 | 140 | 2 | GO:1900005 | |
| GeneOntologyBiologicalProcess | G protein-coupled dopamine receptor signaling pathway | 2.24e-04 | 44 | 140 | 4 | GO:0007212 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | NPY1R CYP26B1 ATG7 ABCA12 RDH13 ITPR1 SLC5A5 DHRS9 KCNMA1 GNA11 GNAQ GNAS ABCC2 GNAZ | 2.36e-04 | 684 | 140 | 14 | GO:0010817 |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | SEMG1 SEMG2 CNTRL PRAMEF1 PRAMEF2 PRAMEF13 PIK3CA PRAMEF14 HFM1 GNAS CFAP69 VPS13B | 2.57e-04 | 527 | 140 | 12 | GO:0022412 |
| GeneOntologyBiologicalProcess | negative regulation of cilium-dependent cell motility | 2.72e-04 | 4 | 140 | 2 | GO:1902020 | |
| GeneOntologyBiologicalProcess | negative regulation of cilium movement | 2.72e-04 | 4 | 140 | 2 | GO:0003354 | |
| GeneOntologyBiologicalProcess | negative regulation of flagellated sperm motility | 2.72e-04 | 4 | 140 | 2 | GO:1901318 | |
| GeneOntologyBiologicalProcess | mating plug formation | 2.72e-04 | 4 | 140 | 2 | GO:0042628 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.39e-06 | 13 | 142 | 4 | GO:0002116 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 3.71e-06 | 35 | 142 | 5 | GO:0005834 | |
| GeneOntologyCellularComponent | GTPase complex | 8.30e-06 | 41 | 142 | 5 | GO:1905360 | |
| GeneOntologyCellularComponent | cilium | DNAH3 EVC2 PTCHD3 DNAH10 ATG7 DYNC2H1 CNTRL RTTN PRAMEF1 PRAMEF2 PRAMEF13 DNAH14 SPAG5 TTLL7 KIFAP3 GNA11 GNAQ USP48 CFAP69 | 1.10e-05 | 898 | 142 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 2.50e-05 | 9 | 142 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | dynein complex | 3.26e-05 | 54 | 142 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 3.90e-05 | 56 | 142 | 5 | GO:0031234 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 4.87e-05 | 11 | 142 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 8.43e-05 | 206 | 142 | 8 | GO:0001669 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.17e-04 | 161 | 142 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.80e-04 | 230 | 142 | 8 | GO:0098562 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 2.90e-04 | 47 | 142 | 4 | GO:0031462 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.24e-04 | 317 | 142 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 3.50e-04 | 137 | 142 | 6 | GO:0019897 | |
| GeneOntologyCellularComponent | secretory granule | SEMG1 SEMG2 CAB39 NPY1R ATG7 ABCA12 PRAMEF1 PRAMEF2 PRAMEF13 STK11IP CLEC12A ITPR1 ITPR2 ITPR3 ARSA PLA1A VPS13B | 5.31e-04 | 1014 | 142 | 17 | GO:0030141 |
| GeneOntologyCellularComponent | axoneme | 5.43e-04 | 207 | 142 | 7 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 5.59e-04 | 208 | 142 | 7 | GO:0097014 | |
| GeneOntologyCellularComponent | motile cilium | DNAH3 PTCHD3 DNAH10 DYNC2H1 PRAMEF1 PRAMEF2 PRAMEF13 DNAH14 CFAP69 | 7.33e-04 | 355 | 142 | 9 | GO:0031514 |
| GeneOntologyCellularComponent | secretory vesicle | SEMG1 SEMG2 CAB39 NPY1R ATG7 ABCA12 NTF3 PRAMEF1 PRAMEF2 PRAMEF13 STK11IP CLEC12A ITPR1 ITPR2 ITPR3 ARSA PLA1A ANP32E VPS13B | 7.85e-04 | 1246 | 142 | 19 | GO:0099503 |
| GeneOntologyCellularComponent | cytoplasmic region | 8.09e-04 | 360 | 142 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.01e-03 | 230 | 142 | 7 | GO:0019898 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 1.68e-03 | 185 | 142 | 6 | GO:0009898 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.99e-03 | 10 | 142 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | supramolecular fiber | CAB39 DNAH3 DNAH10 MYO6 DYNC2H1 DCTN2 NCKIPSD MYO18A HAUS3 DNAH14 SPAG5 TTLL7 KIFAP3 DST LRRC27 SCN5A MYBPC2 | 2.70e-03 | 1179 | 142 | 17 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CAB39 DNAH3 DNAH10 MYO6 DYNC2H1 DCTN2 NCKIPSD MYO18A HAUS3 DNAH14 SPAG5 TTLL7 KIFAP3 DST LRRC27 SCN5A MYBPC2 | 2.90e-03 | 1187 | 142 | 17 | GO:0099081 |
| GeneOntologyCellularComponent | axon | NPY1R ATG7 MYO6 DCTN2 NTF3 N4BP3 ARMCX3 ITPR2 SLIT2 DST SACS SCN5A KCNMA1 WDFY3 | 3.02e-03 | 891 | 142 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | microtubule | DNAH3 DNAH10 DYNC2H1 DCTN2 HAUS3 DNAH14 SPAG5 TTLL7 KIFAP3 DST | 3.53e-03 | 533 | 142 | 10 | GO:0005874 |
| MousePheno | abnormal male germ cell apoptosis | CYP26B1 RAD21L1 PRAMEF1 PRAMEF2 PRAMEF13 ELMO1 RAD51AP2 ARSA PRAMEF14 VPS13B | 1.95e-05 | 236 | 112 | 10 | MP:0008280 |
| MousePheno | abnormal male germ cell physiology | CYP26B1 RAD21L1 PRAMEF1 PRAMEF2 PRAMEF13 ELMO1 RAD51AP2 ARSA PRAMEF14 VPS13B | 2.60e-05 | 244 | 112 | 10 | MP:0020362 |
| MousePheno | abnormal germ cell physiology | CYP26B1 RAD21L1 PRAMEF1 PRAMEF2 PRAMEF13 ELMO1 RAD51AP2 ARSA PRAMEF14 VPS13B | 5.58e-05 | 267 | 112 | 10 | MP:0020363 |
| Domain | - | CNTRL SLITRK4 KERA CPN2 PRAMEF1 PRAMEF2 SHOC2 PRAMEF13 STK11IP TLR10 SLIT2 LRRC27 ANP32E LRRC8B LRRD1 | 2.12e-08 | 321 | 141 | 15 | 3.80.10.10 |
| Domain | L_dom-like | CNTRL SLITRK4 KERA CPN2 PRAMEF1 PRAMEF2 SHOC2 PRAMEF13 STK11IP TLR10 SLIT2 LRRC27 ANP32E LRRC8B LRRD1 | 2.82e-08 | 328 | 141 | 15 | IPR032675 |
| Domain | LRR | CNTRL SLITRK4 KERA CPN2 SHOC2 STK11IP TLR10 SLIT2 LRRC27 ANP32E LRRC8B LRRD1 | 4.11e-08 | 201 | 141 | 12 | PS51450 |
| Domain | ARM-type_fold | CAB39 SMG1 RTTN ARFGEF1 IPO4 ARMCX3 ELMO1 ITPR1 ITPR2 KIFAP3 PIK3CA UTP20 WDFY3 CFAP69 XPO7 | 4.36e-08 | 339 | 141 | 15 | IPR016024 |
| Domain | GproteinA_insert | 9.33e-08 | 16 | 141 | 5 | IPR011025 | |
| Domain | - | 9.33e-08 | 16 | 141 | 5 | 1.10.400.10 | |
| Domain | G-alpha | 9.33e-08 | 16 | 141 | 5 | PF00503 | |
| Domain | G_alpha | 9.33e-08 | 16 | 141 | 5 | SM00275 | |
| Domain | Gprotein_alpha_su | 1.31e-07 | 17 | 141 | 5 | IPR001019 | |
| Domain | Plexin_cytopl | 3.81e-07 | 9 | 141 | 4 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 3.81e-07 | 9 | 141 | 4 | IPR013548 | |
| Domain | Plexin | 3.81e-07 | 9 | 141 | 4 | IPR031148 | |
| Domain | InsP3_rcpt-bd | 4.21e-07 | 3 | 141 | 3 | IPR000493 | |
| Domain | LRR_1 | CNTRL SLITRK4 KERA CPN2 SHOC2 TLR10 SLIT2 LRRC27 ANP32E LRRC8B LRRD1 | 8.69e-07 | 219 | 141 | 11 | PF00560 |
| Domain | LRR_TYP | CNTRL SLITRK4 KERA CPN2 SHOC2 TLR10 SLIT2 LRRC27 LRRC8B LRRD1 | 9.59e-07 | 177 | 141 | 10 | SM00369 |
| Domain | Leu-rich_rpt_typical-subtyp | CNTRL SLITRK4 KERA CPN2 SHOC2 TLR10 SLIT2 LRRC27 LRRC8B LRRD1 | 9.59e-07 | 177 | 141 | 10 | IPR003591 |
| Domain | ARM-like | CAB39 SMG1 RTTN ARFGEF1 IPO4 ARMCX3 ELMO1 KIFAP3 UTP20 WDFY3 CFAP69 XPO7 | 9.95e-07 | 270 | 141 | 12 | IPR011989 |
| Domain | Leu-rich_rpt | CNTRL SLITRK4 KERA CPN2 SHOC2 STK11IP TLR10 SLIT2 LRRC27 ANP32E LRRC8B LRRD1 | 1.03e-06 | 271 | 141 | 12 | IPR001611 |
| Domain | Gprotein_alpha_Q | 1.68e-06 | 4 | 141 | 3 | IPR000654 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.94e-06 | 14 | 141 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.94e-06 | 14 | 141 | 4 | IPR024743 | |
| Domain | MT | 2.94e-06 | 14 | 141 | 4 | PF12777 | |
| Domain | AAA_8 | 2.94e-06 | 14 | 141 | 4 | PF12780 | |
| Domain | DHC_fam | 3.98e-06 | 15 | 141 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 3.98e-06 | 15 | 141 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.98e-06 | 15 | 141 | 4 | IPR004273 | |
| Domain | LRR_8 | 6.09e-06 | 171 | 141 | 9 | PF13855 | |
| Domain | - | CAB39 RTTN ARFGEF1 IPO4 ARMCX3 ELMO1 KIFAP3 UTP20 WDFY3 CFAP69 | 7.31e-06 | 222 | 141 | 10 | 1.25.10.10 |
| Domain | RIH_assoc-dom | 8.29e-06 | 6 | 141 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 8.29e-06 | 6 | 141 | 3 | PF08709 | |
| Domain | RIH_assoc | 8.29e-06 | 6 | 141 | 3 | PF08454 | |
| Domain | RIH_dom | 8.29e-06 | 6 | 141 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.29e-06 | 6 | 141 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.29e-06 | 6 | 141 | 3 | IPR015925 | |
| Domain | - | 8.29e-06 | 6 | 141 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.29e-06 | 6 | 141 | 3 | PF01365 | |
| Domain | - | DNAH3 SAMD9 DNAH10 ABCA12 DYNC2H1 MYO18A ABCC6 DNAH14 TRANK1 GNA14 ATAD1 ABCA6 HFM1 GNA11 GNAQ GNAS ABCC2 GNAZ | 1.33e-05 | 746 | 141 | 18 | 3.40.50.300 |
| Domain | AAA | 1.37e-05 | 144 | 141 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 1.37e-05 | 144 | 141 | 8 | IPR003593 | |
| Domain | P-loop_NTPase | DNAH3 SAMD9 DNAH10 MYO6 ABCA12 DYNC2H1 MYO18A ABCC6 DNAH14 TRANK1 GNA14 ATAD1 ABCA6 HFM1 GNA11 GNAQ GNAS ABCC2 GNAZ | 2.12e-05 | 848 | 141 | 19 | IPR027417 |
| Domain | IPT | 4.77e-05 | 27 | 141 | 4 | SM00429 | |
| Domain | MIR | 4.86e-05 | 10 | 141 | 3 | PF02815 | |
| Domain | MIR_motif | 4.86e-05 | 10 | 141 | 3 | IPR016093 | |
| Domain | MIR | 4.86e-05 | 10 | 141 | 3 | PS50919 | |
| Domain | MIR | 4.86e-05 | 10 | 141 | 3 | SM00472 | |
| Domain | Rho_GTPase_activation_prot | 5.42e-05 | 88 | 141 | 6 | IPR008936 | |
| Domain | TMEM131-like | 5.66e-05 | 2 | 141 | 2 | IPR022113 | |
| Domain | TMEM131_like | 5.66e-05 | 2 | 141 | 2 | PF12371 | |
| Domain | Semenogelin | 5.66e-05 | 2 | 141 | 2 | PF05474 | |
| Domain | Semenogelin | 5.66e-05 | 2 | 141 | 2 | IPR008836 | |
| Domain | Semap_dom | 8.36e-05 | 31 | 141 | 4 | IPR001627 | |
| Domain | SEMA | 8.36e-05 | 31 | 141 | 4 | PS51004 | |
| Domain | TIG | 8.36e-05 | 31 | 141 | 4 | PF01833 | |
| Domain | Sema | 8.36e-05 | 31 | 141 | 4 | SM00630 | |
| Domain | Sema | 8.36e-05 | 31 | 141 | 4 | PF01403 | |
| Domain | IPT | 9.50e-05 | 32 | 141 | 4 | IPR002909 | |
| Domain | Plexin_repeat | 9.50e-05 | 32 | 141 | 4 | IPR002165 | |
| Domain | PSI | 9.50e-05 | 32 | 141 | 4 | PF01437 | |
| Domain | Dynein_heavy_dom-2 | 1.44e-04 | 14 | 141 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.44e-04 | 14 | 141 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.44e-04 | 14 | 141 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.44e-04 | 14 | 141 | 3 | PF07728 | |
| Domain | RasGAP_dom | 3.16e-04 | 18 | 141 | 3 | IPR001936 | |
| Domain | PSI | 3.34e-04 | 44 | 141 | 4 | IPR016201 | |
| Domain | Multidrug-R_assoc | 3.36e-04 | 4 | 141 | 2 | IPR005292 | |
| Domain | PRAME_family | 3.74e-04 | 19 | 141 | 3 | IPR026271 | |
| Domain | PSI | 3.97e-04 | 46 | 141 | 4 | SM00423 | |
| Domain | ABC_tran | 4.68e-04 | 48 | 141 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 4.68e-04 | 48 | 141 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.07e-04 | 49 | 141 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 5.48e-04 | 50 | 141 | 4 | IPR003439 | |
| Domain | LRRNT | 6.84e-04 | 53 | 141 | 4 | PF01462 | |
| Domain | DHC_N1 | 1.54e-03 | 8 | 141 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.54e-03 | 8 | 141 | 2 | IPR013594 | |
| Domain | TPR_REGION | 1.59e-03 | 165 | 141 | 6 | PS50293 | |
| Domain | TPR | 1.59e-03 | 165 | 141 | 6 | PS50005 | |
| Domain | Ion_trans_dom | 1.74e-03 | 114 | 141 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.74e-03 | 114 | 141 | 5 | PF00520 | |
| Domain | NPY_rcpt | 1.97e-03 | 9 | 141 | 2 | IPR000611 | |
| Domain | TPR-like_helical_dom | 1.98e-03 | 233 | 141 | 7 | IPR011990 | |
| Domain | IQ | 3.30e-03 | 81 | 141 | 4 | SM00015 | |
| Domain | ABC_A | 3.55e-03 | 12 | 141 | 2 | IPR026082 | |
| Domain | ABC_transporter_CS | 3.90e-03 | 42 | 141 | 3 | IPR017871 | |
| Domain | Cys-rich_flank_reg_C | 4.82e-03 | 90 | 141 | 4 | IPR000483 | |
| Domain | LRRCT | 4.82e-03 | 90 | 141 | 4 | SM00082 | |
| Domain | IQ_motif_EF-hand-BS | 4.82e-03 | 90 | 141 | 4 | IPR000048 | |
| Domain | IMPORTIN_B_NT | 4.85e-03 | 14 | 141 | 2 | PS50166 | |
| Domain | IQ | 5.41e-03 | 93 | 141 | 4 | PS50096 | |
| Domain | PI3/4_kinase_CS | 5.57e-03 | 15 | 141 | 2 | IPR018936 | |
| Domain | IBN_N | 5.57e-03 | 15 | 141 | 2 | PF03810 | |
| Domain | TPR-contain_dom | 5.64e-03 | 150 | 141 | 5 | IPR013026 | |
| Domain | - | 6.34e-03 | 16 | 141 | 2 | 1.10.1070.11 | |
| Domain | IBN_N | 6.34e-03 | 16 | 141 | 2 | SM00913 | |
| Domain | PI3Kc | 6.34e-03 | 16 | 141 | 2 | SM00146 | |
| Domain | - | 6.34e-03 | 16 | 141 | 2 | 1.10.506.10 | |
| Domain | LRRNT | 6.50e-03 | 98 | 141 | 4 | IPR000372 | |
| Domain | LRRNT | 6.50e-03 | 98 | 141 | 4 | SM00013 | |
| Domain | Importin-beta_N | 7.15e-03 | 17 | 141 | 2 | IPR001494 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.05e-07 | 61 | 104 | 7 | MM15071 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 5.67e-07 | 10 | 104 | 4 | M47661 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 7.94e-07 | 70 | 104 | 7 | M8232 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 8.87e-07 | 11 | 104 | 4 | M49033 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 9.64e-07 | 72 | 104 | 7 | MM14631 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.67e-06 | 78 | 104 | 7 | M1921 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 1.70e-06 | 50 | 104 | 6 | M47951 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.90e-06 | 13 | 104 | 4 | M47656 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.70e-06 | 54 | 104 | 6 | M26911 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 3.86e-06 | 5 | 104 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 7.68e-06 | 6 | 104 | 3 | M47960 | |
| Pathway | PID_ER_NONGENOMIC_PATHWAY | 1.06e-05 | 40 | 104 | 5 | M41 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 1.24e-05 | 20 | 104 | 4 | M47688 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.47e-05 | 108 | 104 | 7 | M17034 | |
| Pathway | PID_S1P_META_PATHWAY | 1.52e-05 | 21 | 104 | 4 | M155 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 1.52e-05 | 21 | 104 | 4 | M47689 | |
| Pathway | PID_THROMBIN_PAR1_PATHWAY | 1.53e-05 | 43 | 104 | 5 | M238 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 1.71e-05 | 44 | 104 | 5 | M39845 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.85e-05 | 22 | 104 | 4 | M39795 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.85e-05 | 22 | 104 | 4 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.85e-05 | 22 | 104 | 4 | M47675 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | NPY1R SUCNR1 ITPR1 ITPR2 ITPR3 GNA14 GNA11 CCR5 GNAQ GNAS GNAZ | 1.99e-05 | 314 | 104 | 11 | M600 |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 2.13e-05 | 8 | 104 | 3 | MM15032 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 2.13e-05 | 8 | 104 | 3 | M27356 | |
| Pathway | REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION | 2.13e-05 | 8 | 104 | 3 | MM15100 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 2.21e-05 | 115 | 104 | 7 | M9387 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.22e-05 | 23 | 104 | 4 | M47676 | |
| Pathway | PID_S1P_S1P2_PATHWAY | 2.65e-05 | 24 | 104 | 4 | M268 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 3.17e-05 | 9 | 104 | 3 | MM15030 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 3.17e-05 | 9 | 104 | 3 | M47852 | |
| Pathway | REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION | 4.51e-05 | 10 | 104 | 3 | M1825 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 5.26e-05 | 90 | 104 | 6 | M6467 | |
| Pathway | KEGG_GAP_JUNCTION | 5.26e-05 | 90 | 104 | 6 | M4013 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 5.26e-05 | 90 | 104 | 6 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 5.60e-05 | 91 | 104 | 6 | M39426 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 5.76e-05 | 29 | 104 | 4 | M55 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 6.17e-05 | 11 | 104 | 3 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 6.17e-05 | 11 | 104 | 3 | MM15035 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 6.17e-05 | 11 | 104 | 3 | M27466 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPY1R MC2R SUCNR1 ITPR1 ITPR2 ITPR3 PROKR1 GNA14 PIK3CA GNA11 CCR5 GNAQ GNAS GNAZ PLXNB1 | 7.56e-05 | 646 | 104 | 15 | MM14962 |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 8.58e-05 | 32 | 104 | 4 | MM14983 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.00e-04 | 101 | 104 | 6 | M1979 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.06e-04 | 13 | 104 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.06e-04 | 13 | 104 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.06e-04 | 13 | 104 | 3 | MM14553 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.06e-04 | 147 | 104 | 7 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.26e-04 | 151 | 104 | 7 | M39329 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 1.34e-04 | 14 | 104 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 1.34e-04 | 14 | 104 | 3 | M7578 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.37e-04 | 36 | 104 | 4 | M1315 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.61e-04 | 210 | 104 | 8 | MM15043 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.66e-04 | 15 | 104 | 3 | MM15031 | |
| Pathway | PID_THROMBIN_PAR4_PATHWAY | 1.66e-04 | 15 | 104 | 3 | M138 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | NPY1R MC2R SUCNR1 ITPR1 ITPR2 ITPR3 PROKR1 GNA14 PIK3CA GNA11 CCR5 GNAQ GNAS GNAZ PLXNB1 | 1.90e-04 | 702 | 104 | 15 | M746 |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 2.01e-04 | 217 | 104 | 8 | M18437 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 2.04e-04 | 16 | 104 | 3 | M16498 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.04e-04 | 16 | 104 | 3 | M26945 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 2.04e-04 | 16 | 104 | 3 | M8245 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.52e-04 | 42 | 104 | 4 | M791 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 2.94e-04 | 18 | 104 | 3 | M673 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 3.02e-04 | 44 | 104 | 4 | M11911 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 3.02e-04 | 44 | 104 | 4 | M42554 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 3.02e-04 | 44 | 104 | 4 | M9011 | |
| Pathway | SIG_CHEMOTAXIS | 3.30e-04 | 45 | 104 | 4 | M5193 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.45e-04 | 178 | 104 | 7 | M2890 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 3.47e-04 | 19 | 104 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.47e-04 | 19 | 104 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 3.47e-04 | 19 | 104 | 3 | M47733 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 3.60e-04 | 46 | 104 | 4 | M8626 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF28 KCTD13 MYO6 KTN1 ARMCX3 DST PIK3CA IQGAP3 PLXNA1 PLXNB1 ARHGAP19 | 3.89e-04 | 439 | 104 | 11 | MM15595 |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 4.30e-04 | 86 | 104 | 5 | M916 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGEF28 KCTD13 MYO6 KTN1 ARMCX3 DST PIK3CA IQGAP3 PLXNA1 PLXNB1 ARHGAP19 | 4.79e-04 | 450 | 104 | 11 | M27078 |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 5.35e-04 | 51 | 104 | 4 | MM14967 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 5.42e-04 | 22 | 104 | 3 | M27445 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 6.59e-04 | 143 | 104 | 6 | M27107 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 7.05e-04 | 24 | 104 | 3 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 7.05e-04 | 24 | 104 | 3 | MM15088 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 7.05e-04 | 24 | 104 | 3 | M18308 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 7.05e-04 | 24 | 104 | 3 | MM14794 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 7.93e-04 | 6 | 104 | 2 | M47548 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K | 7.93e-04 | 6 | 104 | 2 | M27929 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 7.97e-04 | 25 | 104 | 3 | MM15056 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 7.97e-04 | 25 | 104 | 3 | M811 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 7.97e-04 | 25 | 104 | 3 | MM14511 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGEF28 KCTD13 MYO6 KTN1 NCKIPSD NUF2 ARMCX3 DST PIK3CA IQGAP3 PLXNA1 PLXNB1 ARHGAP19 | 9.56e-04 | 649 | 104 | 13 | MM15690 |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.00e-03 | 27 | 104 | 3 | MM15053 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.00e-03 | 27 | 104 | 3 | M12123 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.00e-03 | 27 | 104 | 3 | M47755 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.11e-03 | 106 | 104 | 5 | M27077 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.12e-03 | 28 | 104 | 3 | MM15188 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.12e-03 | 28 | 104 | 3 | M924 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.18e-03 | 219 | 104 | 7 | M29836 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.19e-03 | 63 | 104 | 4 | M8 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.26e-03 | 64 | 104 | 4 | M7923 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 1.34e-03 | 65 | 104 | 4 | M15 | |
| Pathway | WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS | 1.37e-03 | 30 | 104 | 3 | M42578 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 1.51e-03 | 31 | 104 | 3 | M661 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.51e-03 | 31 | 104 | 3 | M47507 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 1.66e-03 | 32 | 104 | 3 | M861 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 1.66e-03 | 32 | 104 | 3 | MM15148 | |
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 2.30e-11 | 15 | 145 | 6 | 28578927 | |
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 2.90e-10 | 4 | 145 | 4 | 8570614 | |
| Pubmed | 2.00e-08 | 8 | 145 | 4 | 15661641 | ||
| Pubmed | 3.59e-08 | 9 | 145 | 4 | 19909241 | ||
| Pubmed | 5.97e-08 | 10 | 145 | 4 | 8588930 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 10874040 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 20395455 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 17437169 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 18547250 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 36350267 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 11413485 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 7.10e-08 | 3 | 145 | 3 | 1693919 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 23955339 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 7.10e-08 | 3 | 145 | 3 | 24904548 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 31189994 | ||
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 7.10e-08 | 3 | 145 | 3 | 9858485 | |
| Pubmed | G(q/11)α and G(s)α mediate distinct physiological responses to central melanocortins. | 7.10e-08 | 3 | 145 | 3 | 26595811 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 9808793 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 8806646 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 33166186 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 18194433 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 7.10e-08 | 3 | 145 | 3 | 27777977 | |
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 7.10e-08 | 3 | 145 | 3 | 11241833 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 7.10e-08 | 3 | 145 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 7.10e-08 | 3 | 145 | 3 | 18241669 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 19068129 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 17327232 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 16014380 | ||
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 17890015 | ||
| Pubmed | GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. | 7.10e-08 | 3 | 145 | 3 | 30204251 | |
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 7.10e-08 | 3 | 145 | 3 | 23983250 | |
| Pubmed | 7.10e-08 | 3 | 145 | 3 | 20427533 | ||
| Pubmed | 1.07e-07 | 28 | 145 | 5 | 18617019 | ||
| Pubmed | 1.07e-07 | 28 | 145 | 5 | 8858601 | ||
| Pubmed | Diversity of the G-protein family: sequences from five additional alpha subunits in the mouse. | 1.40e-07 | 12 | 145 | 4 | 2508088 | |
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 1.40e-07 | 12 | 145 | 4 | 21270798 | |
| Pubmed | 2.01e-07 | 13 | 145 | 4 | 10520995 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 25215520 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 9765251 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 2.83e-07 | 4 | 145 | 3 | 25518740 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 34864945 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 10725340 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 11163362 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 11524429 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 2.83e-07 | 4 | 145 | 3 | 21424589 | |
| Pubmed | Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice. | 2.83e-07 | 4 | 145 | 3 | 9687499 | |
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 28615414 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 10828023 | ||
| Pubmed | 2.83e-07 | 4 | 145 | 3 | 28419336 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 2.83e-07 | 4 | 145 | 3 | 35494252 | |
| Pubmed | 3.82e-07 | 15 | 145 | 4 | 11118617 | ||
| Pubmed | 5.07e-07 | 16 | 145 | 4 | 17356169 | ||
| Pubmed | 6.61e-07 | 17 | 145 | 4 | 11683995 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 6.61e-07 | 17 | 145 | 4 | 17626059 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 27566546 | ||
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 25313870 | ||
| Pubmed | Loss of gq/11 genes does not abolish melanopsin phototransduction. | 7.05e-07 | 5 | 145 | 3 | 24870805 | |
| Pubmed | An Acetate-Specific GPCR, FFAR2, Regulates Insulin Secretion. | 7.05e-07 | 5 | 145 | 3 | 26075576 | |
| Pubmed | 7.05e-07 | 5 | 145 | 3 | 11443126 | ||
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 7.05e-07 | 5 | 145 | 3 | 21568942 | |
| Pubmed | The heterotrimeric G protein subunits Gα(q) and Gβ(1) have lysophospholipase D activity. | 7.05e-07 | 5 | 145 | 3 | 21812758 | |
| Pubmed | 8.48e-07 | 18 | 145 | 4 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 8.48e-07 | 18 | 145 | 4 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 8.48e-07 | 18 | 145 | 4 | 29731491 | |
| Pubmed | 8.48e-07 | 18 | 145 | 4 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 1.07e-06 | 19 | 145 | 4 | 28604677 | |
| Pubmed | 1.28e-06 | 187 | 145 | 8 | 26460568 | ||
| Pubmed | 1.33e-06 | 20 | 145 | 4 | 26694250 | ||
| Pubmed | 1.33e-06 | 20 | 145 | 4 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.33e-06 | 20 | 145 | 4 | 21425410 | |
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 23463619 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.41e-06 | 6 | 145 | 3 | 25966694 | |
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 1.41e-06 | 6 | 145 | 3 | 19480842 | |
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 17194762 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 1.41e-06 | 6 | 145 | 3 | 21762810 | |
| Pubmed | Using siRNA to define functional interactions between melanopsin and multiple G Protein partners. | 1.41e-06 | 6 | 145 | 3 | 24958088 | |
| Pubmed | 1.41e-06 | 6 | 145 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.41e-06 | 6 | 145 | 3 | 16844763 | |
| Pubmed | KTN1 ARFGEF1 STK11IP ARMCX3 ITPR1 ITPR2 ITPR3 DST TMEM131L TMEM131 PLXNA1 VPS13B | 1.49e-06 | 504 | 145 | 12 | 34432599 | |
| Pubmed | 1.57e-06 | 47 | 145 | 5 | 35462405 | ||
| Pubmed | Evolution of the mammalian G protein alpha subunit multigene family. | 1.93e-06 | 49 | 145 | 5 | 1302014 | |
| Pubmed | 2.00e-06 | 22 | 145 | 4 | 31729367 | ||
| Pubmed | 2.00e-06 | 22 | 145 | 4 | 8894702 | ||
| Pubmed | 2.41e-06 | 23 | 145 | 4 | 19480014 | ||
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 2.45e-06 | 7 | 145 | 3 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 2.45e-06 | 7 | 145 | 3 | 19655386 | |
| Pubmed | 2.45e-06 | 7 | 145 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 2.45e-06 | 7 | 145 | 3 | 22495310 | |
| Pubmed | Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. | 2.45e-06 | 7 | 145 | 3 | 10520994 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | PLXNA3 DPY19L3 MAN2A1 KTN1 SLITRK4 ARFGEF1 NEK9 SPAG5 ITPR1 ITPR2 MGAT5 ARSA TMEM131L UTP20 TMEM131 USP48 PLXNA1 PLXNB1 | 2.86e-06 | 1201 | 145 | 18 | 35696571 |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 2.89e-06 | 24 | 145 | 4 | 28893946 | |
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 3.42e-06 | 25 | 145 | 4 | 12620990 | |
| Pubmed | 3.42e-06 | 25 | 145 | 4 | 37451217 | ||
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 3.91e-06 | 8 | 145 | 3 | 22368082 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 4.03e-06 | 26 | 145 | 4 | 18500982 | |
| Pubmed | 5.49e-06 | 28 | 145 | 4 | 25089626 | ||
| Pubmed | Protease-activated receptors in hemostasis, thrombosis and vascular biology. | 5.85e-06 | 9 | 145 | 3 | 16102047 | |
| Interaction | RHOA interactions | CNKSR1 ARHGEF28 KCTD13 MYO6 KTN1 SLITRK4 MYO18A IPO4 STK11IP ARMCX3 ITPR1 ITPR2 ITPR3 ATAD1 UTP20 GNA11 GNAS USP48 IQGAP3 PLXNA1 VPS13B PLXNB1 PMAIP1 ARHGAP19 | 3.29e-06 | 1199 | 142 | 24 | int:RHOA |
| Interaction | RIC8A interactions | 5.25e-06 | 96 | 142 | 7 | int:RIC8A | |
| Interaction | CAPZA2 interactions | KCTD13 MYO6 DCTN2 KTN1 NCKIPSD MYO18A N4BP3 ITPR1 ITPR2 ITPR3 DST NUDCD1 USP48 | 1.14e-05 | 430 | 142 | 13 | int:CAPZA2 |
| Interaction | SEMA5A interactions | 1.17e-05 | 7 | 142 | 3 | int:SEMA5A | |
| Interaction | TPPP interactions | 1.96e-05 | 47 | 142 | 5 | int:TPPP | |
| Interaction | GNG3 interactions | 2.25e-05 | 24 | 142 | 4 | int:GNG3 | |
| Interaction | GNGT1 interactions | 3.13e-05 | 26 | 142 | 4 | int:GNGT1 | |
| Interaction | GNAO1 interactions | 4.21e-05 | 132 | 142 | 7 | int:GNAO1 | |
| Interaction | TAFA4 interactions | 4.24e-05 | 55 | 142 | 5 | int:TAFA4 | |
| Interaction | GNAQ interactions | 4.86e-05 | 135 | 142 | 7 | int:GNAQ | |
| Interaction | CNPY3 interactions | 7.66e-05 | 196 | 142 | 8 | int:CNPY3 | |
| Interaction | ISG20 interactions | 9.30e-05 | 13 | 142 | 3 | int:ISG20 | |
| Interaction | SCGB2A1 interactions | 9.48e-05 | 104 | 142 | 6 | int:SCGB2A1 | |
| Interaction | CCDC22 interactions | 1.03e-04 | 152 | 142 | 7 | int:CCDC22 | |
| Interaction | IRAG1 interactions | 1.18e-04 | 14 | 142 | 3 | int:IRAG1 | |
| Interaction | DEFA5 interactions | 1.36e-04 | 70 | 142 | 5 | int:DEFA5 | |
| Interaction | FIBIN interactions | 1.45e-04 | 71 | 142 | 5 | int:FIBIN | |
| Interaction | SEMA5B interactions | 1.46e-04 | 15 | 142 | 3 | int:SEMA5B | |
| Interaction | CTRB2 interactions | 1.47e-04 | 3 | 142 | 2 | int:CTRB2 | |
| Interaction | EDNRB interactions | 1.60e-04 | 39 | 142 | 4 | int:EDNRB | |
| Interaction | NPTN interactions | 1.61e-04 | 278 | 142 | 9 | int:NPTN | |
| Interaction | RAB7A interactions | KCTD13 ATG7 KTN1 CNTRL ARFGEF1 TRIM39 STK11IP ARMCX3 ITPR1 ITPR2 ITPR3 DST TMEM131L TMEM131 PLXNA1 VPS13B PMAIP1 | 1.70e-04 | 886 | 142 | 17 | int:RAB7A |
| Interaction | TESPA1 interactions | 1.79e-04 | 16 | 142 | 3 | int:TESPA1 | |
| Interaction | ARHGEF12 interactions | 1.81e-04 | 117 | 142 | 6 | int:ARHGEF12 | |
| Cytoband | 1p36.21 | 4.92e-05 | 63 | 145 | 4 | 1p36.21 | |
| GeneFamily | Plexins | 6.48e-08 | 9 | 88 | 4 | 683 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.11e-07 | 3 | 88 | 3 | 297 | |
| GeneFamily | PRAME family | 5.17e-06 | 24 | 88 | 4 | 686 | |
| GeneFamily | Dyneins, axonemal | 7.21e-05 | 17 | 88 | 3 | 536 | |
| GeneFamily | ATP binding cassette subfamily C | 1.76e-03 | 13 | 88 | 2 | 807 | |
| GeneFamily | ATP binding cassette subfamily A | 2.05e-03 | 14 | 88 | 2 | 805 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN | 3.99e-06 | 165 | 145 | 8 | M6685 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | DPY19L3 MAN2A1 MYO18A NUF2 N4BP3 ELMO1 TTLL7 ITPR1 SACS KCNMA1 TMEM131L WDFY3 GNAS GNAZ PLXNA1 VPS13B PLXNA2 XPO7 | 1.24e-05 | 1009 | 145 | 18 | M157 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYO6 CWC27 ICE2 KTN1 ARFGEF1 HAUS3 NUF2 ARMCX3 TTLL7 ITPR1 ITPR2 SACS PIK3CA USP48 | 1.77e-05 | 656 | 145 | 14 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAN2A1 ARFGEF1 SHOC2 ITPR1 KIFAP3 SLIT2 MGAT5 DST SACS TMEM131L UTP20 TMEM131 GNAQ WDFY3 VPS13B ARHGAP19 | 2.22e-05 | 856 | 145 | 16 | M4500 |
| Coexpression | GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN | 3.84e-05 | 165 | 145 | 7 | M353 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-06 | 169 | 144 | 7 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-06 | 117 | 144 | 6 | e74dd01ccb6cc630759146655fccec359f725b1d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-06 | 117 | 144 | 6 | 3c67e8a184b5a8302cba584e5ee97006f6cd267f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.38e-06 | 118 | 144 | 6 | d95344ef24a1a838232186c02725f556c5fd51ac | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-dn_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.38e-06 | 118 | 144 | 6 | c234ea1969726356ee47d9364b716044cfbd125a | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-06 | 199 | 144 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 3.92e-06 | 199 | 144 | 7 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 1.10e-05 | 154 | 144 | 6 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 156 | 144 | 6 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-05 | 157 | 144 | 6 | 904cd98ae85ed6459e0663f077ac462842bf12df | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 158 | 144 | 6 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 158 | 144 | 6 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | facs-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 161 | 144 | 6 | 45591addc765760db6029ac19e80573373d1d917 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 161 | 144 | 6 | 8741b91a62c9a8ce377ef6533d323b65beb93c63 | |
| ToppCell | facs-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-05 | 161 | 144 | 6 | 9cf1dcf0e7ca9e35c46c094a6b78f98d1f6b9276 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.66e-05 | 180 | 144 | 6 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.20e-05 | 186 | 144 | 6 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.40e-05 | 188 | 144 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 189 | 144 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-05 | 190 | 144 | 6 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.60e-05 | 190 | 144 | 6 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.60e-05 | 190 | 144 | 6 | cd37ccd30c27cf65eda0a9165f35b7672f5acaf6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-05 | 191 | 144 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.71e-05 | 191 | 144 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | COVID-19_Mild-dn_T|COVID-19_Mild / Disease condition and Cell class | 3.78e-05 | 116 | 144 | 5 | 79c918f3bebfd5e0b865d2c7673af9ee3bc48779 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.93e-05 | 193 | 144 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.93e-05 | 193 | 144 | 6 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-dn_T|COVID-19_Mild / Disease group, lineage and cell class | 3.93e-05 | 117 | 144 | 5 | 9d417dd137c27f8fe9e57842cd5515fdc2f2dc06 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 194 | 144 | 6 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.05e-05 | 194 | 144 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-05 | 195 | 144 | 6 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 195 | 144 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 195 | 144 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 4.28e-05 | 196 | 144 | 6 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 4.28e-05 | 196 | 144 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 197 | 144 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 197 | 144 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 197 | 144 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | mild-dn_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.41e-05 | 197 | 144 | 6 | 07a1f59c83b748825e0708cd1cc7b63a2cb856cc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 197 | 144 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.53e-05 | 198 | 144 | 6 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.53e-05 | 198 | 144 | 6 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 4.66e-05 | 199 | 144 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.66e-05 | 199 | 144 | 6 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.66e-05 | 199 | 144 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 144 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.99e-05 | 132 | 144 | 5 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 133 | 144 | 5 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 141 | 144 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.55e-05 | 141 | 144 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 142 | 144 | 5 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | 15-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 1.12e-04 | 146 | 144 | 5 | ca722a89c6601e78f253d9484d01931f26161820 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-04 | 146 | 144 | 5 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5-Dad1_(Cspg5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 78 | 144 | 4 | 83d308b15cb3c0820a27b95c8bc85afadf98370e | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5-Dad1_(Cspg5)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 78 | 144 | 4 | 387e7e07a5a509dc8415a7cb83a2c3940ca1ec85 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.24e-04 | 149 | 144 | 5 | 89faa84af68d4727180f39718964bb3bc65d8fe6 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-04 | 154 | 144 | 5 | 6c1e7682c43c40b58b371c58deb10b839700ebcc | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.53e-04 | 156 | 144 | 5 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 157 | 144 | 5 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 159 | 144 | 5 | 3bab00f8fb7d9232538e50f83dd0fd70ddd16819 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Cytotoxic_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.68e-04 | 159 | 144 | 5 | 2060e7ed5627976b48fea4a2328762b6fa308db1 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 160 | 144 | 5 | 5bec867def73fa8531f8dad611679f4b44f573bd | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 163 | 144 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 163 | 144 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-04 | 164 | 144 | 5 | 5638d95c7cc5e59c4a7bda30268a904a01861a5f | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-04 | 165 | 144 | 5 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.99e-04 | 165 | 144 | 5 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-04 | 165 | 144 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 2.11e-04 | 167 | 144 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 167 | 144 | 5 | 528493896aebe7d03d4b6ad2341b12927859e2e4 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 167 | 144 | 5 | a82e85caf79395baa48380786d9df32a86dfd1ce | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-04 | 167 | 144 | 5 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 168 | 144 | 5 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-mDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-04 | 168 | 144 | 5 | 2dca1c4a33b6da9357fa3b2a523af19baab1c21c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 169 | 144 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-04 | 169 | 144 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-04 | 169 | 144 | 5 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.23e-04 | 169 | 144 | 5 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-04 | 170 | 144 | 5 | 3cbeea6bfa500928c413b1c6129f6dedc769cd1e | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-04 | 171 | 144 | 5 | 25c1979e972c959e1ce4c57804f976f53a247ad7 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Goblet|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.35e-04 | 171 | 144 | 5 | fe27bf581c75ef33c2848878e51ed16b275a4c8e | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-mDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-04 | 172 | 144 | 5 | cc0e2a45fa74ee19e41612c3615729462474003a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-04 | 94 | 144 | 4 | 00b932421d77f0fd8d6ffe439c992ebc95ad7c94 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 174 | 144 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-04 | 174 | 144 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | ASK452-Immune-B_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.55e-04 | 174 | 144 | 5 | 69723f5666abc3af5f0431901a60246c9915ef81 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-04 | 95 | 144 | 4 | a09443e527d37adb637a66ca857525dab1c39a9b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 175 | 144 | 5 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 175 | 144 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.61e-04 | 175 | 144 | 5 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 175 | 144 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-04 | 176 | 144 | 5 | 90f8bb11f339f67f08692a0c33dd420f5cda2861 | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-04 | 176 | 144 | 5 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 2.75e-04 | 177 | 144 | 5 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.75e-04 | 177 | 144 | 5 | 52c2ba74a8605260a2623e7d151286e504ac4d19 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-04 | 178 | 144 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 179 | 144 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-04 | 179 | 144 | 5 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 2.98e-04 | 180 | 144 | 5 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-CLC+_Mast_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-04 | 181 | 144 | 5 | 338c7362d258a87f1a6b1a65376f5394d4b2b4b2 | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 5.63e-06 | 200 | 145 | 9 | 5601_UP | |
| Drug | Ns 004 | 1.38e-05 | 8 | 145 | 3 | CID000162750 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.83e-05 | 177 | 145 | 8 | 4652_DN | |
| Drug | magnesium fluoride | 2.19e-05 | 53 | 145 | 5 | CID000024546 | |
| Drug | caged InsP3 | 3.31e-05 | 29 | 145 | 4 | CID000122248 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HG-U133A | 3.67e-05 | 195 | 145 | 8 | 450_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 3.95e-05 | 197 | 145 | 8 | 2810_UP | |
| Drug | 8-amino-cADPR | 4.02e-05 | 11 | 145 | 3 | CID003081323 | |
| Drug | BOCPheONP | 4.03e-05 | 2 | 145 | 2 | CID000111308 | |
| Drug | MPM-06 | 4.03e-05 | 2 | 145 | 2 | CID000161546 | |
| Drug | NSC-374899 | 4.03e-05 | 2 | 145 | 2 | CID000435726 | |
| Drug | adenophostin A | 4.03e-05 | 2 | 145 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 4.03e-05 | 2 | 145 | 2 | CID000001326 | |
| Drug | methylbenzenebutanoate | 4.03e-05 | 2 | 145 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 4.03e-05 | 2 | 145 | 2 | CID004418081 | |
| Drug | adenophostin B | 4.03e-05 | 2 | 145 | 2 | CID000656722 | |
| Drug | c189 | 4.03e-05 | 2 | 145 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 4.03e-05 | 2 | 145 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 4.03e-05 | 2 | 145 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 4.03e-05 | 2 | 145 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 4.03e-05 | 2 | 145 | 2 | CID000074924 | |
| Drug | p-toluamidine | 4.03e-05 | 2 | 145 | 2 | CID000122753 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 4.03e-05 | 2 | 145 | 2 | CID000191275 | |
| Drug | benzene 1,2,4-trisphosphate | 4.03e-05 | 2 | 145 | 2 | CID000192376 | |
| Drug | isobutyl sulfide | 4.03e-05 | 2 | 145 | 2 | CID000011607 | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 1uM; MCF7; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 4383_UP | |
| Drug | Caffeic acid [3331-39-5]; Up 200; 22.2uM; HL60; HT_HG-U133A | 4.09e-05 | 198 | 145 | 8 | 3053_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A | 4.24e-05 | 199 | 145 | 8 | 7308_UP | |
| Drug | S 2484 | 8.75e-05 | 14 | 145 | 3 | CID000135164 | |
| Drug | Clorgyline | 1.03e-04 | 168 | 145 | 7 | ctd:D003010 | |
| Drug | MX-68 | 1.09e-04 | 15 | 145 | 3 | CID006918310 | |
| Drug | AHBs | 1.09e-04 | 15 | 145 | 3 | CID000193414 | |
| Drug | hexaconazole | 1.16e-04 | 119 | 145 | 6 | ctd:C409722 | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 1.20e-04 | 3 | 145 | 2 | CID000195110 | |
| Drug | N-acetylbenzotriazole | 1.20e-04 | 3 | 145 | 2 | CID000087784 | |
| Drug | photophor | 1.20e-04 | 3 | 145 | 2 | CID000014780 | |
| Drug | dibutyl iodomethaneboronate | 1.20e-04 | 3 | 145 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 1.20e-04 | 3 | 145 | 2 | CID004309911 | |
| Drug | 2-oxobut-3-ynoate | 1.20e-04 | 3 | 145 | 2 | CID000171547 | |
| Drug | AFMeq | 1.20e-04 | 3 | 145 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 1.20e-04 | 3 | 145 | 2 | CID006452691 | |
| Drug | n-(2-oxoethyl)benzamide | 1.20e-04 | 3 | 145 | 2 | CID000188995 | |
| Drug | AC1L49DM | 1.20e-04 | 3 | 145 | 2 | CID000152933 | |
| Drug | c140 | 1.20e-04 | 3 | 145 | 2 | CID002783250 | |
| Drug | Benzamidomethaneboronic acid | 1.20e-04 | 3 | 145 | 2 | CID000127677 | |
| Drug | phenyl hippurate | 1.20e-04 | 3 | 145 | 2 | CID000076323 | |
| Drug | FK-386 | 1.20e-04 | 3 | 145 | 2 | CID000135044 | |
| Drug | FK-375 | 1.20e-04 | 3 | 145 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 1.20e-04 | 3 | 145 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 1.20e-04 | 3 | 145 | 2 | CID000328214 | |
| Drug | C18 4 | 1.20e-04 | 3 | 145 | 2 | CID000077248 | |
| Drug | taraxastane | 1.20e-04 | 3 | 145 | 2 | CID006429404 | |
| Drug | Phe-phe-ome | 1.20e-04 | 3 | 145 | 2 | CID000151728 | |
| Drug | phenylethaneboronic acid | 1.20e-04 | 3 | 145 | 2 | CID000065389 | |
| Drug | 3-amino-2-pyridone | 1.20e-04 | 3 | 145 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 1.20e-04 | 3 | 145 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 1.20e-04 | 3 | 145 | 2 | CID000070396 | |
| Drug | Z-Phe-OMe | 1.20e-04 | 3 | 145 | 2 | CID003082435 | |
| Drug | 3-methylcoumarin | 1.20e-04 | 3 | 145 | 2 | CID000017130 | |
| Drug | 2-propyl methylphosphonochloridate | 1.20e-04 | 3 | 145 | 2 | CID000102124 | |
| Drug | FK-316 | 1.20e-04 | 3 | 145 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 1.20e-04 | 3 | 145 | 2 | CID000000694 | |
| Drug | Marinostatin D | 1.20e-04 | 3 | 145 | 2 | CID000132206 | |
| Drug | 1FD7 | 1.20e-04 | 3 | 145 | 2 | CID000445579 | |
| Drug | Glt-leu-phe-nh-meq | 1.20e-04 | 3 | 145 | 2 | CID000194914 | |
| Drug | AC1L4Z4F | 1.20e-04 | 3 | 145 | 2 | CID000194913 | |
| Drug | Glt-Phe-NH-FMeq | 1.20e-04 | 3 | 145 | 2 | CID000194912 | |
| Drug | diacetyl trimer | 1.20e-04 | 3 | 145 | 2 | CID000193527 | |
| Drug | FK-448 | 1.20e-04 | 3 | 145 | 2 | CID006917869 | |
| Drug | Ac-Phe-OMe | 1.20e-04 | 3 | 145 | 2 | CID000097805 | |
| Drug | thiobenzyl N-heptafluorobutyrylanthranilate | 1.20e-04 | 3 | 145 | 2 | CID000133906 | |
| Drug | hp 5B | 2.27e-04 | 19 | 145 | 3 | CID000123651 | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HG-U133A | 2.28e-04 | 191 | 145 | 7 | 224_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.36e-04 | 192 | 145 | 7 | 4342_DN | |
| Drug | Benzoyl-dl-leucine | 2.40e-04 | 4 | 145 | 2 | CID000294887 | |
| Drug | Acafcek | 2.40e-04 | 4 | 145 | 2 | CID000197677 | |
| Drug | B-1,3-od | 2.40e-04 | 4 | 145 | 2 | CID011971053 | |
| Drug | fluorexon | 2.40e-04 | 4 | 145 | 2 | ctd:C007740 | |
| Drug | dehydromerodesmosine | 2.40e-04 | 4 | 145 | 2 | CID006443540 | |
| Drug | alpha-amyrin palmitate | 2.40e-04 | 4 | 145 | 2 | CID000185477 | |
| Drug | poly-THIQ | 2.40e-04 | 4 | 145 | 2 | CID006453487 | |
| Drug | N-(4-carboxycyclohexylmethyl)-maleimide | 2.40e-04 | 4 | 145 | 2 | CID011548799 | |
| Drug | G2505_sigma | 2.40e-04 | 4 | 145 | 2 | CID000111098 | |
| Drug | p-fluorobenzenesulfonyl chloride | 2.40e-04 | 4 | 145 | 2 | CID000009588 | |
| Drug | BSSDA | 2.40e-04 | 4 | 145 | 2 | CID003081106 | |
| Drug | CHEBI:697555 | 2.40e-04 | 4 | 145 | 2 | CID009578246 | |
| Drug | AC1L2HV6 | 2.40e-04 | 4 | 145 | 2 | CID000047328 | |
| Drug | AC1L4X1Z | 2.40e-04 | 4 | 145 | 2 | CID000193815 | |
| Drug | NSC-676827 | 2.40e-04 | 4 | 145 | 2 | CID000385555 | |
| Drug | 6-amino-1,2-benzopyrone | 2.40e-04 | 4 | 145 | 2 | CID000046152 | |
| Drug | nitrophenylethanol | 2.40e-04 | 4 | 145 | 2 | CID000097851 | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.43e-04 | 193 | 145 | 7 | 3943_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.51e-04 | 194 | 145 | 7 | 4660_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.51e-04 | 194 | 145 | 7 | 4727_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.51e-04 | 194 | 145 | 7 | 2223_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 2.59e-04 | 195 | 145 | 7 | 2624_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.59e-04 | 195 | 145 | 7 | 5702_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; HL60; HT_HG-U133A | 2.59e-04 | 195 | 145 | 7 | 2173_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 2.59e-04 | 195 | 145 | 7 | 4396_DN | |
| Drug | Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.67e-04 | 196 | 145 | 7 | 6483_UP | |
| Disease | obesity (implicated_via_orthology) | 7.36e-07 | 215 | 136 | 9 | DOID:9970 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 2.04e-05 | 12 | 136 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Hypoxic Brain Damage | 2.11e-05 | 2 | 136 | 2 | C1140716 | |
| Disease | level of chymotrypsinogen B2 in blood serum | 2.11e-05 | 2 | 136 | 2 | OBA_2041192 | |
| Disease | Anoxic Encephalopathy | 2.11e-05 | 2 | 136 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 2.11e-05 | 2 | 136 | 2 | C1527348 | |
| Disease | Phakomatosis cesioflammea | 2.11e-05 | 2 | 136 | 2 | C3838883 | |
| Disease | Anoxia of brain | 2.11e-05 | 2 | 136 | 2 | C0995195 | |
| Disease | Congenital hemangioma | 2.11e-05 | 2 | 136 | 2 | C0235753 | |
| Disease | Port-wine stain with oculocutaneous melanosis | 2.11e-05 | 2 | 136 | 2 | C1274879 | |
| Disease | chymotrypsinogen B measurement | 6.31e-05 | 3 | 136 | 2 | EFO_0801477 | |
| Disease | Ichthyosis Congenita I | 1.26e-04 | 4 | 136 | 2 | C4551630 | |
| Disease | Harlequin Fetus | 1.26e-04 | 4 | 136 | 2 | C0239849 | |
| Disease | Ichthyosis Congenita II | 1.26e-04 | 4 | 136 | 2 | C3536797 | |
| Disease | Collodion Fetus | 1.26e-04 | 4 | 136 | 2 | C3543867 | |
| Disease | calcium measurement | ICE2 MYO18A PHTF2 ABCC6 ITPR1 ABCA6 HFM1 GNA11 TMEM131 GNAQ GNAS | 1.64e-04 | 628 | 136 | 11 | EFO_0004838 |
| Disease | Congenital ichthyosis | 2.09e-04 | 5 | 136 | 2 | C0020758 | |
| Disease | Malignant melanoma of iris | 2.09e-04 | 5 | 136 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 2.09e-04 | 5 | 136 | 2 | C0346388 | |
| Disease | X-11423--O-sulfo-L-tyrosine measurement | 3.13e-04 | 6 | 136 | 2 | EFO_0021231 | |
| Disease | mental or behavioural disorder, substance abuse | 3.13e-04 | 6 | 136 | 2 | EFO_0000677, MONDO_0002491 | |
| Disease | Colorectal Carcinoma | DNAH3 EVC2 ABCA12 ARFGEF1 ABCC6 ATAD1 ABCA6 SACS PIK3CA GNAS ABCC2 | 4.23e-04 | 702 | 136 | 11 | C0009402 |
| Disease | able to hear with hearing aids | 4.36e-04 | 7 | 136 | 2 | EFO_0009720 | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 5.80e-04 | 8 | 136 | 2 | EFO_0008151 | |
| Disease | Uveal melanoma | 5.80e-04 | 8 | 136 | 2 | C0220633 | |
| Disease | Cutaneous Melanoma | 8.98e-04 | 41 | 136 | 3 | C0151779 | |
| Disease | quality of life during menstruation measurement, aggressive behavior | 9.26e-04 | 10 | 136 | 2 | EFO_0003015, EFO_0009366 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 1.13e-03 | 11 | 136 | 2 | C0079154 | |
| Disease | Congenital ichthyosis of skin | 1.13e-03 | 11 | 136 | 2 | cv:C0020758 | |
| Disease | trypsin-2 measurement | 1.13e-03 | 11 | 136 | 2 | EFO_0008305 | |
| Disease | pancreatic cancer (is_marker_for) | 1.25e-03 | 101 | 136 | 4 | DOID:1793 (is_marker_for) | |
| Disease | response to carboplatin, methylcobalamin deficiency type cblE, response to antineoplastic agent | 1.35e-03 | 12 | 136 | 2 | GO_0097327, GO_0097328, MONDO_0009354 | |
| Disease | Adenocarcinoma Of Esophagus | 1.85e-03 | 14 | 136 | 2 | C0279628 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.87e-03 | 189 | 136 | 5 | EFO_0009932 | |
| Disease | Obesity | 2.66e-03 | 205 | 136 | 5 | C0028754 | |
| Disease | QT interval | 3.41e-03 | 534 | 136 | 8 | EFO_0004682 | |
| Disease | age at onset, smoking initiation | 3.43e-03 | 19 | 136 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | ovarian neoplasm | 3.49e-03 | 134 | 136 | 4 | C0919267 | |
| Disease | Grand Mal Status Epilepticus | 3.70e-03 | 67 | 136 | 3 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 3.70e-03 | 67 | 136 | 3 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.70e-03 | 67 | 136 | 3 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.70e-03 | 67 | 136 | 3 | C0751523 | |
| Disease | Petit mal status | 3.70e-03 | 67 | 136 | 3 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.70e-03 | 67 | 136 | 3 | C0393734 | |
| Disease | Malignant neoplasm of ovary | 3.78e-03 | 137 | 136 | 4 | C1140680 | |
| Disease | Status Epilepticus | 3.86e-03 | 68 | 136 | 3 | C0038220 | |
| Disease | gestational age | 3.88e-03 | 138 | 136 | 4 | EFO_0005112 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 4.02e-03 | 69 | 136 | 3 | EFO_0007788, EFO_0008002 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 4.59e-03 | 22 | 136 | 2 | DOID:4947 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLLKNIELFDKLALR | 191 | Q8WZ19 | |
| KFSILTVNNDITLLK | 111 | Q6GPI1 | |
| LTKQDNLALIKSLNL | 91 | Q7Z7A1 | |
| LFQNLSKLELLSLSK | 356 | P22792 | |
| LKQNKEVLELAFSIL | 631 | Q92556 | |
| LALLNQFKSKLTQAI | 386 | Q6UX04 | |
| NLSLLEQLKKLQAIV | 296 | Q68CJ9 | |
| FSLRLLINESLIKKL | 2201 | Q86UK0 | |
| LLLFLTKVLKISDNR | 1781 | Q9Y6D6 | |
| LLKKAVLTNLVVFLL | 321 | Q8N139 | |
| ILDILLKNQAKLIEF | 291 | Q9Y376 | |
| VEALQNLKNLKSLDL | 106 | Q9BTT0 | |
| VLCLTLFLNNIIKKI | 351 | Q6ZPD9 | |
| LFLNNIIKKILNLKS | 356 | Q6ZPD9 | |
| VLLAKQLAALKQQLV | 136 | Q13561 | |
| KNFQTLKIVILGLVL | 191 | P51681 | |
| NEETKLQVLKLLLNL | 256 | Q9UH62 | |
| IQQLFQKLKLLSLSQ | 621 | O94823 | |
| LDRFLLQKQLSKVLL | 26 | Q9Y3T6 | |
| LDILLKTNIAFLLNN | 576 | Q09MP3 | |
| LVLKKQLAIELSQSA | 526 | Q9H4I0 | |
| NSSVILFLNKKDLLE | 266 | P50148 | |
| LVLQLKNNASKLLLA | 2036 | Q14571 | |
| ETKLKILEILQFILN | 966 | Q14573 | |
| LFVLTTKNLFLIKVN | 566 | Q96RS6 | |
| IQKALSDAFQKLLIV | 206 | Q8NG50 | |
| LALLLTDVLLFLQEK | 1106 | Q8N1W1 | |
| NKLTFLAVEIFQLLK | 336 | A4D1F6 | |
| LQFLNILKTSNSIKL | 286 | Q12791 | |
| DIKTLNIFLTKANLI | 176 | Q8TD19 | |
| LVQKLLNKFIVESLT | 1096 | Q16706 | |
| DLKKTLAVLLDNILQ | 81 | Q09328 | |
| DLVLELKNNASKLLL | 2091 | Q14643 | |
| KQLVKLTRLLFNLSE | 851 | Q6ZRQ5 | |
| LVLKNTQAAEALVKL | 1176 | Q03001 | |
| VTKEFFLLLLKELLN | 746 | Q15034 | |
| LAKLFLKVLAVELAS | 446 | Q9NR63 | |
| VIFKQLLQAKALQFL | 311 | Q7L5Y1 | |
| GVLKQLLSDLIEKNL | 1406 | Q9UIW2 | |
| ALKLFAQLINNKVFL | 1351 | O75051 | |
| GLLKQLLADLIEKNL | 1381 | P51805 | |
| LSNLLNSKLFLTKFI | 1606 | O43157 | |
| KLKSQEIFLNLKTAL | 416 | Q9BZD4 | |
| LLQDSQKKIISNLFL | 961 | Q92614 | |
| VALLLLQLSAALKFL | 281 | Q6ZS72 | |
| QISKDIIALLLKNLT | 401 | Q86UK5 | |
| NLLKAQLNETLTKLR | 1256 | Q86UP2 | |
| VLLKSFLLKLVNDIF | 321 | Q92887 | |
| LKQLQLLKAQLDAAV | 456 | P15289 | |
| LNSLIIKLIQADILK | 31 | P20783 | |
| LIEKINFLLSALVIL | 191 | Q8NGM8 | |
| QSKQFDLCLLLALIK | 461 | Q86Y13 | |
| LLQLFKTALQEEIKS | 1006 | Q86VI3 | |
| NVNLLIFLLNKKFLR | 1616 | Q86VI3 | |
| DNLLVRFLLKKALTN | 646 | P42336 | |
| ALAFLEENLKILRLK | 481 | Q6P9F7 | |
| FLLTNLLLDKLKASA | 151 | Q8NBN7 | |
| AQEKKFAVLLNSLIL | 901 | A2PYH4 | |
| SGNLALIIIILKQKE | 56 | P25929 | |
| TLDVVVLLLALAKKN | 496 | Q9UP65 | |
| DLIQKLFDLLVLSLK | 921 | Q8NCM8 | |
| LFDLLVLSLKKSIQA | 926 | Q8NCM8 | |
| LNFRQKLLNLISKLF | 36 | Q13794 | |
| KLVVLLNQLCSILAK | 161 | Q05DH4 | |
| EKLSALKISNLFNIL | 831 | Q659A1 | |
| LFNILQHILKKLSSL | 841 | Q659A1 | |
| INTSLILFLNKKDLL | 261 | P19086 | |
| VLLNKFLLLTFADLK | 126 | O95352 | |
| LLLQLKQELEILQKS | 301 | Q86Z20 | |
| ELILTFKTLLNSKRQ | 2656 | Q8TD57 | |
| LILVKIKALNQAESF | 751 | P16383 | |
| NSSVILFLNKKDLLE | 266 | P29992 | |
| SVILFLNKQDLLAEK | 286 | P63092 | |
| QLIKQKASFELLQLS | 376 | Q68CZ6 | |
| LSADKFQVLLAELKQ | 176 | Q9H0A8 | |
| ALLIVANSFLKEKVN | 2176 | Q0VDD8 | |
| LLFKAQQLTDLEQKL | 171 | Q86TE4 | |
| ILINFKATKFLNLNL | 186 | O75342 | |
| NILLINKVNEKSLTL | 351 | Q9Y2T3 | |
| DLKAKQLLLSDILNT | 5031 | Q8NDH2 | |
| KSNFALLLKLSEELL | 136 | Q6UW02 | |
| NNLETLLKRDFLKLL | 46 | Q9UKT8 | |
| IFLLLDLLALNQKKF | 611 | A5D8W1 | |
| DLLALNQKKFCNLIL | 616 | A5D8W1 | |
| LQDFLLLKQKAELAN | 301 | Q9BPW9 | |
| VLTKLILKNLQSFNS | 871 | Q8IVF4 | |
| LQQTNLKLFHSLKLL | 3121 | Q9NZJ4 | |
| KAALLLLLTFLAKQH | 1041 | Q8TEX9 | |
| KFSILTVNNDITLLK | 111 | P17538 | |
| NFELLILVVSFLKKL | 316 | Q92845 | |
| LLDQFTNIKNILALK | 346 | Q3KNS1 | |
| LEHLQLLKIKLITFF | 266 | Q5VWM6 | |
| LNSSVILFLNKKDLL | 261 | O95837 | |
| QLQKELIALFDTLLL | 1206 | Q86VV8 | |
| VFQTQLALKLLQCLK | 1236 | Q86VV8 | |
| QFLFDVLQKTLSLKL | 76 | Q8N1F8 | |
| KLKVLILNDNLISFL | 156 | Q8IW52 | |
| EALAILAKLILNKAA | 441 | O75691 | |
| LQKAIDLFTDAIKLN | 126 | Q8IZP2 | |
| ELTLVNNVLKLATKL | 721 | Q8N3S3 | |
| FALRKILKQLIADVT | 326 | Q9HCM9 | |
| LQSLTLFLQTKLKEK | 881 | Q96R06 | |
| NAKTSVLLLNKVDLL | 241 | Q9BXR5 | |
| LKLAVKDIAINLFTN | 456 | A2VDJ0 | |
| LQDEVLKLKLGLTLN | 476 | Q9C0I9 | |
| KAFVTLTVLNILNKA | 566 | O95255 | |
| SVFLRLEHLQLLKIK | 261 | Q5SWL7 | |
| LEHLQLLKIKLITFF | 266 | Q5SWL7 | |
| QSKEKLNFILANIIL | 1381 | Q5K651 | |
| ILFLNKQDLLAEKVL | 931 | Q5JWF2 | |
| KEKIQNLSLISLANL | 231 | Q8TDQ0 | |
| INKLLNKLFLINEQS | 251 | Q6NW34 | |
| NKLVLVKQLDNILAA | 181 | Q96Q15 | |
| ALSQLKKLLFLFLED | 116 | O60938 | |
| IFVLSLLLILEKQAA | 6 | P04279 | |
| KINILAKINLLFVAI | 1556 | Q14524 | |
| LFLLLFVVIKQLKNS | 21 | Q4W5P6 | |
| SLEVLILSNNLLKKL | 426 | Q9UQ13 | |
| LFVLSLLLILEKQAA | 6 | Q02383 | |
| SVFLRLEHLQLLKIK | 261 | O95521 | |
| LEHLQLLKIKLITFF | 266 | O95521 | |
| EQLKILNLRFLGKLL | 1071 | O00267 | |
| SVFLRLEHLQLLKIK | 261 | O60811 | |
| LEHLQLLKIKLITFF | 266 | O60811 | |
| AALQELLSKGLIKLV | 86 | P62851 | |
| ANVKIFSEKLLLLLN | 581 | Q9NZQ3 | |
| ENLIVLLAVFKNKNL | 41 | Q01718 | |
| RKKNLTLALEALVQL | 236 | Q9H553 | |
| QKLAAAVFSLAIKLQ | 171 | Q8NBU5 | |
| ASLLKINNKNALEFI | 166 | Q5QGZ9 | |
| LQSTLKAKLQELQVL | 626 | Q969H4 | |
| KKLRNLTNLLIANLA | 91 | Q8TCW9 | |
| LKDLAFLKNQLESLQ | 11 | L0R6Q1 | |
| VIKLSLEISLFLNKL | 136 | Q53H76 | |
| LVVLLSNQSILIKFK | 1691 | Q8IZQ1 | |
| KLLIDFIIQLIAQSK | 2066 | Q8IZQ1 | |
| KQAKLALLINQVGLF | 276 | Q92911 | |
| QTQKKFVILALQLLL | 1266 | A6NE52 | |
| LLLIQSLKNNLIEKD | 851 | Q07617 | |
| KLSLQTLNADIFLKQ | 1581 | Q92545 | |
| LFSLQLLLLNANKIN | 371 | O94813 | |
| NLLKLLLDLLYQTAK | 241 | Q14CB8 | |
| HLLQKKEFAILISLA | 131 | Q9BXA5 | |
| LFAVNEFILLNLLKV | 161 | Q9UBD6 | |
| ENFILLFSKVKLQSL | 581 | Q86TV6 | |
| LKANLSFTKLDQINL | 2051 | Q7Z7G8 | |
| SFTKLDQINLFLKKI | 2056 | Q7Z7G8 | |
| LDNALQTFIKLLLSI | 861 | Q9UIA9 | |
| NLNLTVTLQDKLLKL | 1216 | Q6R2W3 | |
| LLDLLVKFDINFNLK | 566 | O15050 | |
| ALLVSANQTLKELKI | 946 | Q86UV5 | |
| ELQLRLLALQSASKK | 371 | O60293 | |
| LLKKLLQLQALTEGE | 76 | Q3YBR2 | |
| LQNLEKTIFCLQKLI | 111 | Q96EF9 | |
| LLNALKLLNIRTSDK | 371 | Q6ZT98 | |
| ISVGNKFKTQLNLLL | 641 | Q9UM54 | |
| LAQKLAEIFSLKTQL | 391 | O15049 | |
| ALSLSAKLNFLEIKV | 516 | Q14324 |